Brief: Laurus Labs Received Establishment Inspection Report (Eir) From USFDA For Facility At Visakhapatnam, Andhra Pradesh
15/06/2023 10:43
June 15 (Reuters) - Laurus Labs Ltd LAUL.NS :
* RECEIVED ESTABLISHMENT INSPECTION REPORT (EIR) FROM USFDA
FOR
FACILITY AT VISAKHAPATNAM, ANDHRA PRADESH
Source text for Eikon: ID:nBSE6B1vyb
Further company coverage: LAUL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Laurus Labs
See all newsIndia's Laurus Labs hits record high as Q2 profit more than doubles
Brief: Laurus Labs Declares Dividend Of 1 Rupee Per Share
Brief: Laurus Labs Invests 1.08 Billion Rupees Into KRKA Pharma Via Rights Issue
Brief: Laurus Labs Invests 120.96 Million Rupees In Kurnool Renewables Via Rights Issue
Four Indian stocks to be added, three removed from key global index in MSCI's August rejig